Washington, D.C. (January 7, 2016) — LUNGevity Foundation today issued a Request for Applications (RFA) for the 2016 Career Development Awards for Translational Research. These awards support innovative work by researchers in the first five years of their faculty appointment. The RFA is available on the LUNGevity website at www.lungevity.org/apply-for-grant and is also posted on the proposalCENTRAL website at https://proposalcentral.altum.com.
LUNGevity’s Career Development Awards for Translational Research program was created to support future scientific leaders who will keep the field of lung cancer research vibrant with new ideas. The Career Development Awards are mentored awards, and a mentoring plan is part of the required submission. Successful applicants may receive $100,000 per year for a period of three years and will participate as non-voting members of LUNGevity’s Scientific Advisory Board for the duration of the award.
Awards for 2016 will be granted to projects that have a direct impact on the early detection or outcomes of lung cancer or that provide a clear conceptual or experimental foundation for the future development of methods for early detection and/or individualized treatment, including through immuno-oncology.
Letters of intent must be submitted by Wednesday, February 17, 2016.
LUNGevity supports the largest research awards program of any lung cancer-focused organization in the United States. Since 2002, LUNGevity has funded 115 projects at 58 institutions in 23 states.
About Lung Cancer
- 1 in 15 Americans will be diagnosed with lung cancer in their lifetime
- More than 221,000 people in the U.S. will be diagnosed with lung cancer this year
- About 60%-65% of all new lung cancer diagnoses are among people who have never smoked or are former smokers
- Lung cancer takes more lives than the next three leading cancers (colorectal, breast, and prostate) combined
- Only 17% of all people diagnosed with lung cancer will survive 5 years or more, BUT if it’s caught before it spreads, the chance for 5-year survival improves dramatically
About LUNGevity Foundation
LUNGevity Foundation is firmly committed to making an immediate impact on increasing quality of life and survivorship of people with lung cancer by accelerating research into early detection and more effective treatments, as well as by providing community, support, and education for all those affected by the disease. Our vision is a world where no one dies of lung cancer. For more information about LUNGevity Foundation, please visit www.LUNGevity.org.